KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionDivestmentsDividends Paid - CommonDividends Paid - CommonExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares IssuedShares RepurchasedShort-Term Debt issuancesShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Teradyne (TER) Gains from Sales and Divestitures (2016 - 2025)

Teradyne filings provide 14 years of Gains from Sales and Divestitures readings, the most recent being $455000.0 for Q4 2025.

  • On a quarterly basis, Gains from Sales and Divestitures fell 7.52% to $455000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $455000.0, a 7.52% decrease, with the full-year FY2025 number at $455000.0, down 7.52% from a year prior.
  • Gains from Sales and Divestitures hit $455000.0 in Q4 2025 for Teradyne, down from $492000.0 in the prior quarter.
  • In the past five years, Gains from Sales and Divestitures ranged from a high of $749000.0 in Q4 2021 to a low of $455000.0 in Q4 2025.
  • Median Gains from Sales and Divestitures over the past 5 years was $609000.0 (2023), compared with a mean of $602800.0.
  • Biggest five-year swings in Gains from Sales and Divestitures: fell 5.34% in 2022 and later fell 19.21% in 2024.
  • Teradyne's Gains from Sales and Divestitures stood at $749000.0 in 2021, then decreased by 5.34% to $709000.0 in 2022, then dropped by 14.1% to $609000.0 in 2023, then fell by 19.21% to $492000.0 in 2024, then dropped by 7.52% to $455000.0 in 2025.
  • The last three reported values for Gains from Sales and Divestitures were $455000.0 (Q4 2025), $492000.0 (Q4 2024), and $609000.0 (Q4 2023) per Business Quant data.